Patient Enrollment Marketing for Phase IIB OAB Drug- North America, South America, Western Europe, Eastern Europe, Asia, Australia, Africa

February 9, 2018

Challenge

Retain 700 subjects who completed the first part of the study into a 52-week extension study across six continents.

Solution

ThreeWire developed comprehensive patient retention materials for distribution among global sites. Materials included both site-focused items (e.g., Tips and Techniques for Study Coordinators, Participant Contact Forms and Logs ) and patient-focused items (e.g., study guides, newsletters, greeting cards, certificates of appreciation).

Results

Completed creative development of materials in 13 languages within a month of project award. IRBapproved materials were sent electronically to sponsor for printing and distribution.

Previous Flipbook
Patient Enrollment Marketing for Phase III Pediatric Influenza Vaccine- North America & Europe & Asia
Patient Enrollment Marketing for Phase III Pediatric Influenza Vaccine- North America & Europe & Asia

ThreeWire was called upon to provide study branding and creative services to develop study support material...

Next Flipbook
Pivotal Implant Study Drug Refractory Epilepsy
Pivotal Implant Study Drug Refractory Epilepsy

ThreeWire was called on to assist the sponsor with completing enrollment ahead of multiple competitors with...